Escape velocity out of a small base: management describes the business compounding at a rate its own size cannot absorb
The model's full reasoning — Q4 2022 call → NOThe question asks whether management describes the company as being at a point where the RATE of accumulation has become the dominant fact — i.e., management describes the business in terms of multiples or repeated doublings of its own recent past, and treats the company as still small against what it is already doing. Let me examine the transcript for evidence of this. Key points from the call: - Management discusses product development milestones, FDA submissions, partnerships, IP acquisition. - They discuss the LIVMOR acquisition, which brought IP and a team. - They discuss the AIMI and AIMIGo products, FDA timelines. - They discuss go-to-market strategy, direct pay segments. - Financial results: G&A expenses increased, R&D expenses increased significantly (from $255,000 in 2021 to $5.7 million in 2022 — that's a multiple, but it's expenses, not revenue/activity). - Net loss increased. Now, does management frame the business in terms of multiples of its own recent past? Let me look for specific language. - "we have a very unique data set of patients who actually have recorded their ECG on a daily, weekly or monthly basis" — future potential. - "the application of artificial intelligence will be of great value" — future. - "we remain confident in our anticipated upcoming product milestones" — future. The financials: R&D expenses went from $255,000 to $5.7 million — that's a multiple, but it's expenses, and it's largely because 2021 was pre-IPO. Management doesn't frame this as "we've multiplied our activity" — they just report the numbers. The company is pre-revenue, pre-commercialization. They talk about FDA submissions, product development, partnerships. There's no mention of actual orders, customers, units shipped, deployments, etc. The activity being multiplied would have to be real and already banked — actual orders, customers, sites, units, volumes, etc. Here, there's no such activity. The company hasn't launched a product yet. They're awaiting FDA clearance.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| SNOW | Snowflake Inc. | Q3 2022 | 2021-12-01 | A |
SNOW · Q3 2022 → YESThe question is about whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as st...YES Frank Slootman repeatedly frames the current state in terms of multiples of the recent past: product revenue “growing 110% year-on-year” (more than doubling), EMEA “up 174%” and Asia-Pacific “219%”, BUILD Summit registrations “three times last year’s”, Snow Day “ 23,000 registrations”, Data Marketplace “grew 41%”, stable edges “more than 130% annual increase”, Powered By Snowflake partners “growing 137% quarter-on-quarter” and product revenue from them “173% year-on-year”.
DASH · Q3 2023 → YESThe question is whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as still sm...YES The transcript shows management repeatedly framing the business in terms of multiples of its recent past: non-restaurant selection "going from 0 nearly 3 years ago to a multibillion-dollar business that's at scale now growing fast"; grocery GOV "has doubled year-on-year"; international growth "at multiples of what we see around the world"; and new verticals accelerating from the prior quarter.
SYM · Q3 2022 → YESThe question is about whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as st...YES Management repeatedly frames the current state using multiples of recent past activity: backlog more than doubled (from $5.2B to $11.